Back to search
FDAFDA · Food and drugs·Recall number D-0478-2024

Epinephrine-Lidocaine HCl 0.25 mg/mL and 7.5 mg/mL Preservative-Free, 1 mL Single-Use vials, Rx only, Imprimis NJOF, LLC 1705 Route 46 West, Unit 6B, Ledgewood, NJ, 07852, NDC 71384-640-01

Published May 8, 2024 · Recall initiated: April 10, 2024

Summary

FDA records drug Class III recall D-0478-2024, published May 8, 2024 and initiated April 10, 2024. Recalling firm: Imprimis NJOF, LLC; Status: Ongoing; Reported quantity: 15,414 units; Lot: Lot #: 23JUL028, Exp. Date 8/1/2024; 23AUG053, Exp. Date 8/30/2024. Class III means the product is not likely to cause adverse health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Out of specification for assay

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Imprimis NJOF, LLC
Distributor
Nationwide within the United States
Lot
Lot #: 23JUL028, Exp. Date 8/1/2024; 23AUG053, Exp. Date 8/30/2024
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Epinephrine-Lidocaine HCl 0.25 mg/mL and 7.5 mg/mL Preservative-Free, 1 mL Single-Use vials, Rx only, Imprimis NJOF, LLC 1705 Route 46 West, Unit 6B, Ledgewood, NJ, 07852, NDC 71384-640-01 recalled?

Yes. FDA published recall D-0478-2024 on May 8, 2024. Reported hazard: Out of specification for assay

What should I do if I have this product?

Voluntary: Firm initiated · Letter